Gap Inc (GPS) 28.76 $GPS Looking for a Good Deal on

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Gap Inc (GPS) 28.76 $GPS

Looking for a Good Deal on Retail: GPS, AEO, ASNA, and JWN
ACCESSWIRE - Thu Mar 24, 8:06AM CDT
NEW YORK, NY / ACCESSWIRE / March 24, 2016 / ValuableInvestment.com has tracked the following Apparel Stores stocks for today's review: The Gap Inc. (NYSE: GPS), American Eagle Outfitters Inc. (NYSE: AEO), Ascena Retail Group Inc. (NASDAQ: ASNA), and Nordstrom Inc. (NYSE: JWN). Sign up now to know more about these stocks' performances at:
AEO: 16.32 (-0.04), JWN: 55.97 (-0.07), ASNA: 10.42 (+0.30), GPS: 28.76 (+0.04)

Is The Gap Stock About to Collapse or Can It Stage Another Big Turnaround?
at The Street - Tue Mar 22, 1:57PM CDT
The news for this once-thriving clothing retailer has been grim. We examine what's in store for the stock and whether you should avoid it.
GPS: 28.76 (+0.04)

Dow, S&P 500 Erase 2016 Losses as Crude Recovers $40
at The Street - Thu Mar 17, 1:32PM CDT
Stocks extend 2016 highs on Thursday after crude oil recovers a level above $40 for the first time this year.
GES: 18.64 (-0.10), FDX: 162.65 (+0.02), RDS.A: 48.28 (+0.58), COP: 40.04 (+0.19), XOM: 83.98 (+0.23), WSM: 54.22 (-1.09), GPS: 28.76 (+0.04), CAT: 75.29 (+1.61), LE: 26.30 (+0.48), IGT: 17.59 (+0.17), CVX: 94.85 (+1.26), XLE: 61.84 (+0.30)

Stocks Trade Mixed as Crude Boosts Energy Sector
at The Street - Thu Mar 17, 9:44AM CDT
Stocks trade mixed on Thursday morning after a rally in crude oil boosts the energy sector.
GES: 18.64 (-0.10), FDX: 162.65 (+0.02), RDS.A: 48.28 (+0.58), COP: 40.04 (+0.19), XOM: 83.98 (+0.23), CAT: 75.29 (+1.61), WSM: 54.22 (-1.09), GPS: 28.76 (+0.04), CVX: 94.85 (+1.26), LE: 26.30 (+0.48), IGT: 17.59 (+0.17), XLE: 61.84 (+0.30)

Stock Futures Pull Back After Fed Cheer Fades
at The Street - Thu Mar 17, 7:56AM CDT
Stock futures are lower on Thursday as markets pull back from a Federal Reserve-inspired rally a day earlier.
GES: 18.64 (-0.10), FDX: 162.65 (+0.02), CAT: 75.29 (+1.61), GPS: 28.76 (+0.04), WSM: 54.22 (-1.09)

Gap Inc.'s Commitment to Equality Recognized with 2016 Catalyst Award
Business Wire - Wed Mar 16, 11:00AM CDT
Gap Inc. (NYSE: GPS) announced that Chief Executive Officer Art Peck will today accept the prestigious 2016 Catalyst Award on the company's behalf at the 2016 Catalyst Awards event held in New York City. In selecting Gap Inc. for this year's Award, Catalyst, a leading nonprofit organization accelerating progress for women, recognizes Gap Inc.'s culture of equality and dedicated efforts related to the advancement of women, including employees, customers, and within the broader community.
GPS: 28.76 (+0.04)

Gap (GPS) Stock Stumbles, Morgan Stanley: Fundamentals Still Weak
at The Street - Wed Mar 16, 7:58AM CDT
Gap (GPS) shares are tanking on Wednesday morning after Morgan Stanley slashed its rating on the stock.
GPS: 28.76 (+0.04)

3 Bankrupt Retailers Trying to Rise From the Grave This Year
at The Street - Sat Mar 12, 9:00AM CST
Can a retailer emerge from bankruptcy and drive a turnaround? These three bankrupt retailers are going to give it a whirl.
AMZN: 582.95 (+13.32), ANF: 31.41 (+0.58), AEO: 16.32 (-0.04), SYX: 8.93 (+0.01), WMT: 68.00 (+0.54), BBY: 31.29 (-0.13), GPS: 28.76 (+0.04), SHLD: 15.00 (+0.04), ARO: 0.21 (+0.01)

Zacks Industry Outlook Highlights: Home Depot, Target, Wal-Mart Stores, Abercrombie & Fitch and Gap
Zacks Equity Research - Zacks Investment Research - Fri Mar 11, 8:30AM CST
Zacks Industry Outlook Highlights: Home Depot, Target, Wal-Mart Stores, Abercrombie & Fitch and Gap
HD: 130.46 (+0.24), ANF: 31.41 (+0.58), TGT: 82.04 (+0.54), WMT: 68.00 (+0.54), GPS: 28.76 (+0.04)

Interesting GPS Put And Call Options For April 29th
DividendChannel.com - Thu Mar 10, 9:43AM CST
Investors in The Gap, Inc. saw new options begin trading today, for the April 29th expiration.
GPS: 28.76 (+0.04)

Conns: Leap Year, Super Bowl Timing Drives February Comps
Zacks Equity Research - Zacks Investment Research - Thu Mar 10, 9:40AM CST
Conns (CONN) released positive sales data for the month of February.
CONN: 15.82 (-0.32), GPS: 28.76 (+0.04), BKE: 33.21 (+0.37), RAD: 8.07 (+0.07)

Urban Outfitters Soars and Shake Shack Sinks as Stocks Fall
Demitrios Kalogeropoulos, The Motley Fool - Motley Fool - Tue Mar 08, 6:43PM CST
Stocks couldn't make it five-for-five, as indexes fell today after rising in each of the last four trading sessions. ^INX data by YCharts The Dow Jones Industrial Average  (DJINDICES: ^DJI) shed 110 points, or 0.7%, and the S&P...
URBN: 32.43 (+0.31), SHAK: 32.89 (+0.08), M: 43.48 (+0.06), GPS: 28.76 (+0.04)

3 Stocks to Own for the Next 10 Years
Todd Campbell, Tyler Crowe, and Timothy Green, The Motley Fool - Motley Fool - Tue Mar 08, 7:31AM CST
Image source: Flickr user 401kCalculator.org. It's been shown time and time again that when it comes to investing, thinking long term is a better bet than thinking short term, and while any number of things could go wrong that could derail the...
NOV: 31.15 (-0.23), GPS: 28.76 (+0.04), REGN: 370.80 (+5.42)

What to Watch in the Stock Market This Week
Demitrios Kalogeropoulos, The Motley Fool - Motley Fool - Mon Mar 07, 11:11AM CST
Stocks logged solid gains during the last five trading days, marking the second strong week for blue-chip indexes. The Dow Jones Industrial Average   and the S&P 500  each rose by more than 2% last week, and are now down by roughly the same...
URBN: 32.43 (+0.31), M: 43.48 (+0.06), DG: 83.95 (-0.56), GPS: 28.76 (+0.04)

Uptrend Call Working As Gap Inc Stock Rises 16.2% (GPS)
Comtex SmarTrend(R) - Fri Mar 04, 5:53PM CST
SmarTrend identified an Uptrend for Gap Inc (NYSE:GPS) on February 17th, 2016 at $25.20. In approximately 2 weeks, Gap Inc has returned 16.23% as of today's recent price of $29.29.
GPS: 28.76 (+0.04)

Watch for Gap Inc to Potentially Pullback After Gaining 2.63% Yesterday
Comtex SmarTrend(R) - Fri Mar 04, 5:45PM CST
Gap Inc (NYSE:GPS) traded in a range yesterday that spanned from a low of $28.55 to a high of $29.94. Yesterday, the shares gained 2.6%, which took the trading range above the 3-day high of $28.58 on volume of 8.5 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
GPS: 28.76 (+0.04)

Carmike Cinemas, Hewlett Packard Enterprise climb
AP - Fri Mar 04, 3:54PM CST
NEW YORK (AP) — Stocks that moved substantially or traded heavily Friday on the New York Stock Exchange and the Nasdaq stock market:
SPLS: 10.76 (+0.71), RIG: 9.38 (+0.11), GPS: 28.76 (+0.04), CKEC: 30.46 (+0.38), HPE: 17.57 (+0.11), SWHC: 26.52 (-2.53), HRB: 26.61 (-0.38)

Gap Comps Hurt by Banana Republic, Mark 11th Straight Fall
Zacks Equity Research - Zacks Investment Research - Fri Mar 04, 1:30PM CST
The Gap Inc. (GPS) continued with its dismal sales trend as results for Feb 2016 marked the company's 11th consecutive monthly comparable-store sales (comps) decline.
LB: 85.79 (+0.49), GPS: 28.76 (+0.04), BKE: 33.21 (+0.37), RAD: 8.07 (+0.07)

Will Gap (GPS) Stock Be Hurt by Declining Same-Store Sales?
at The Street - Fri Mar 04, 8:19AM CST
After yesterday's market close, Gap (GPS) reported that comparable-store sales were down in February.
GPS: 28.76 (+0.04)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Step Inside Henson's Creature Shop Magic in NYC

Updated Category News Views 8

Unlock Puppet Magic with Jim Henson Tours Puppet fans, let me tell you, there's something going on in Queens, NY that's got both nostalgia and innovation scribbled all over it. We're talking about the legendary Jim Henson's Creature Shop opening its doors. If you're looking to relive the magic that helped shape a generation, get ready to dive into a world where creativity...

Continue Reading
Streamlined AI Video Analytics for Public Safety Unveiled

Updated Category News Views 2

AI Without the Headache Alright folks, IREX is shaking things up, and not in the usual iterative, bit-by-bit tech progression way. StreamVLM™ has been rolled out as the world's first vision-language model (VLM) analytics engine tailored for the public safety sector—specifically, for cloud platforms. I’ve been around the block enough times to spot a significant shift...

Continue Reading
Lick the Plate Hits 2,000 Shows with Clown Band

Updated Category News Views 5

They say good things come in bizarre packages, and that's exactly the case as David Boylan's Lick the Plate zany celebration marks 15 years on air with its 2,000th episode. If you think of radio as a predictable endeavor, well, you're not tuned into Lick the Plate. A Milepost Draped in Multicolored Fabrics When you're browsing through colorful avenues of radio fame, it's...

Continue Reading
Intus Bio Secures $2.7M for Colorectal Cancer Test

Updated Category News Views 4

Pioneering Efforts in Early-Onset Colorectal Cancer Detection The battlefield of colorectal cancer prevention just got a serious upgrade with Intus Bio grabbing a $2.7 million award. This ain't just pocket change—it's a shot at rewriting the script on how we approach early-onset colorectal cancer, the pesky number one cancer gnawing at the under-50 crowd. Partnering...

Continue Reading
Oil Markets Shift Focus: Pipelines Trump Drilling

Updated Category News Views 5

Decoupling Oil Price and Production Response This oil market isn’t your usual rodeo. With Brent flirting with $100, it’s a seismic shift that’s not yielding new drills but redirecting capital to the existing infrastructure landscape. Ask yourself why we're not seeing the usual cavalry charge of new rigs. It’s simple: Pipeline mileage and producing wells have...

Continue Reading
Crystal Risotti: Leading IT Compliance in Healthcare

Updated Category News Views 6

A Journey Marked by Dedication and Expertise In the demanding world of healthcare technology, where regulations can make or break a company, Crystal Risotti has carved out a space for herself as a leader. Over the last 30 years, she's developed a reputation for blending regulatory expertise with practical business strategies. Her recognition as a Pinnacle Professional of...

Continue Reading
Bitwise Pulls Plug on Dogecoin ETF Amid Market Risks

Updated Category News Views 8

Bitwise Ditches Dogecoin ETF: End of a Speculative Era Who knew that a digital asset inspired by an internet meme would get a platform on Wall Street? Well, Bitwise did. They rallied behind Dogecoin, launching the Bitwise Dogecoin ETF, ticker BWOW. But as of September 10, 2026, the fund's journey is coming to an end with liquidation just around the corner. What Sparked...

Continue Reading
XKL Delivers MediaLight for High-Speed Optical Transport

Updated Category News Views 5

Unpacking the MediaLight Launch Kicking off September, XKL is tossing its hat in the ring with the MediaLight Xponder and Muxponder systems. These aren't just any run-of-the-mill gizmos—nope, they're touted as top-of-the-line optical transport solutions. The talk of the town is their ability to dish out high-density 100G and 400G transport, and for geeks in the trade,...

Continue Reading
Seismic Pharma Kicks Off Phase 3 Trial for Istaroxime

Updated Category News Views 4

Seismic Sets the Stage for a Medical Milestone From the heart of biotech in Durham, North Carolina, seismic waves ripple through the medical community as Seismic Pharmaceuticals embarks on a high-stakes adventure. It's official: they've enrolled their very first patient in the global Phase 3 trial of istaroxime, targeting the grim specter known as cardiogenic shock. You...

Continue Reading
Fermi's Founder Pushes for Board Overhaul: What's Next?

Updated Category News Views 2

Fermi's Roller Coaster: A Founder’s Stand Seems like Fermi Inc. is on a wild ride through the business landscape, and it's giving shareholders more whiplash than satisfaction these days. Toby Neugebauer, co-founder of Fermi and the loudest voice in the room, is feeling like his company is facing some serious turbulence and seems determined not to sit idly by as it hits...

Continue Reading

Top 5 Most Recently Viewed Articles

LenioBio and ReciBioPharm Team Up for Vaccine Tech Advancement

Updated Category News Views 52

LenioBio and ReciBioPharm Team Up for Vaccine Tech Advancement LenioBio, known for its innovative approaches to rapid protein expression, has announced an exciting collaboration with ReciBioPharm, aiming to boost vaccine production and efficiency through advanced technology. This partnership is set to play a vital role in enhancing the capabilities of protein...

Continue Reading
Trump and Cuban's Rivalry Heats Up Amid Tariff Controversy

Updated Category News Views 172

Trump and Cuban's Feud Intensifies Donald Trump recently directed a fierce critique at billionaire Mark Cuban, accusing him of being a "loser" and labeling him as a "weak and pathetic bully." This latest insult arises from a public dispute ignited by Cuban's criticisms regarding Trump's proposed tariff strategies. The Catalyst of the Conflict The discord took a public...

Continue Reading
Cascale Revamps Engagement Model to Enhance Manufacturer Input

Updated Category News Views 77

Cascale Unveils New Membership Engagement Model Cascale, known previously as the Sustainable Apparel Coalition, is implementing a revolutionary member engagement and governance model aimed at ensuring comprehensive participation across its platform. This initiative emphasizes the vital role of suppliers and manufacturers, thereby enhancing decision-making processes within...

Continue Reading
Cosmic Crisp® Joins Forces with Dunford® for Delicious Pastries

Updated Category News Views 283

Cosmic Crisp® Collaborates with Dunford® for New Dessert Launch Cosmic Crisp® is making waves in the dessert market with an exciting collaboration with Dunford®, a brand celebrated for its exquisite pastries. Let’s explore this innovative partnership that introduces unique experiences for dessert lovers. The Launch of a New Pastry Delight The partnership between...

Continue Reading
Silexion Therapeutics Engages Investors with Public Offering

Updated Category News Views 138

Silexion Therapeutics Engages Investors with Public Offering Silexion Therapeutics Corp (NASDAQ: SLXN) is a clinical-stage biotech company focused on developing groundbreaking RNA interference (RNAi) therapies aimed at treating KRAS-driven cancers. Recently, the company announced closing a public offering priced at $1.35 per share, allowing investors to acquire a total of...

Continue Reading